Clinical utility of QuantiFERON TB Gold Test in the diagnosis of latent tuberculosis infections
Submitted: 14 February 2014
Accepted: 14 February 2014
Published: 31 March 2010
Accepted: 14 February 2014
Abstract Views: 820
PDF: 815
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Similar Articles
- Maria Saladino, Salvatore Nisticò, Annelisa Borelli, Vincenzina Caruso, Vilma Villella, Domenico Caruso, Maria Piccoli, Antonella Nicolazzo, Rosa Anna Leone, QuantiFERON® TB GOLD’ s applications in the tuberculosis disease , Microbiologia Medica: Vol. 29 No. 1 (2014)
- Ilaria Sauzullo, Valeria Belvisi, Fernanda Chiarini, Miriam Lichtner, Claudio Maria Mastroianni, Fabio Mengoni, Raffaella Rossi, Vincenzo Vullo, CXCL10/IP10 is a novel potential in vitro marker of TB infection , Microbiologia Medica: Vol. 24 No. 2 (2009)
- Ilaria Sauzullo, Fabio Mengoni, Rossana Scrivo, Guido Valesini, Concetta Potenza, Nevena Skroza, Miriam Lichtner, Raffaella Marocco, Vullo Vincenzo, Claudio Maria Mastroianni, Role of interferon-gamma release assays (IGRAs) for the screening of latent tuberculosis infection in patients candidates for TNF-α antagonist , Microbiologia Medica: Vol. 25 No. 2 (2010)
You may also start an advanced similarity search for this article.